Evidence map›Paper›PMID 38515158›Full record

ArticleCell communication and signaling : CCS2024

Acetyl-CoA synthetase 2 induces pyroptosis and inflammation of renal epithelial tubular cells in sepsis-induced acute kidney injury by upregulating the KLF5/NF-κB pathway.

Jian Lu, Ya Hou, Si-Xiu Liu, Bo Jin, Jing Liu, Nan Li, Yan Zhu, Qing-Yan Zhang, Cheng Wan, Yuan Feng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jian Lu *Department of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Ya Hou *Department of Cardiology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Si-Xiu LiuDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Bo JinDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Jing LiuDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Nan LiDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Yan ZhuDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Qing-Yan ZhangDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Cheng WanDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Yuan FengDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China.
Jun XieMedical School, Nanjing University, Jiangsu Province, Nanjing, 210093, China. xiejun@nju.edu.cn.
Chun-Ming JiangDepartment of Nephrology, the Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Jiangsu Province, Nanjing, 210008, China. guloujiang@sina.com.
Nanjing Drum Tower Hospital · CNNanjing Medical University · CN

Funding

China Postdoctoral Science Foundation 2023M731623National Nature Science Foundation of China 82300816Natural Science Foundation of Nanjing University of Chinese Medicine XZR2023070the Jiangsu Innovative and Entrepreneurial Talent Programme JSSCBS20211515the Nanjing Postdoctoral Science Foundation, and the Key Project Supported by the Medical Science and Technology Development Foundation, Nanjing Department of Health YKK21094
6 · The paper itself

Abstract

backgroundPyroptosis of the renal tubular epithelial cells (RTECs) and interstitial inflammation are central pathological characteristics of acute kidney injury (AKI). Pyroptosis acts as a pro-inflammatory form of programmed cell death and is mainly dependent on activation of the NLRP3 inflammasome. Previous studies revealed that acetyl-CoA synthetase 2 (ACSS2) promotes inflammation during metabolic stress suggesting that ACSS2 might regulate pyroptosis and inflammatory responses of RTECs in AKI. METHODS AND

resultsThe expression of ACSS2 was found to be significantly increased in the renal epithelial cells of mice with lipopolysaccharide (LPS)-induced AKI. Pharmacological and genetic strategies demonstrated that ACSS2 regulated NLRP3-mediated caspase-1 activation and pyroptosis through the stimulation of the KLF5/NF-κB pathway in RTECs. The deletion of ACSS2 attenuated renal tubular pathological injury and inflammatory cell infiltration in an LPS-induced mouse model, and ACSS2-deficient mice displayed impaired NLRP3 activation-mediated pyroptosis and decreased IL-1β production in response to the LPS challenge. In HK-2 cells, ACSS2 deficiency suppressed NLRP3-mediated caspase-1 activation and pyroptosis through the downregulation of the KLF5/NF-κB pathway. The KLF5 inhibitor ML264 suppressed NF-κB activity and NLRP3-mediated caspase-1 activation, thus protecting HK-2 cells from LPS-induced pyroptosis.

conclusionOur results suggested that ACSS2 regulates activation of the NLRP3 inflammasome and pyroptosis by inducing the KLF5/NF-κB pathway in RTECs. These results identified ACSS2 as a potential therapeutic target in AKI.

Indexed as

Acute Kidney InjurySepsisAcetate-CoA LigaseAcetyl Coenzyme AAnimalsCaspase 1Epithelial CellsInflammasomesInflammationLigasesLipopolysaccharidesMiceNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisAcetate-CoA LigaseAcetyl Coenzyme AACSS2 protein, mouseCaspase 1InflammasomesLigasesLipopolysaccharidesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinAcetyl-CoA synthetase 2Acute kidney injuryPyroptosisSepsis

Identifiers

PMID38515158
PMCPMC10958832
OpenAlexW4393056452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.